Posted inBiotechnology
eQTL Links Key Genes to IBD in Colon
A groundbreaking revelation in the intricate world of immunogenetics has emerged from recent research conducted by Nishiyama, Silverstein, Darlington, and…
Posted inBiotechnology
Breakthroughs in Porous Materials Spotlighted by 2025 Nobel Prize in Chemistry
In a groundbreaking development that merges environmental sustainability with advanced materials science, Brazilian researchers have made significant strides in the…
Posted inBiotechnology
Unveiling the Evolution of Sharp Vision: Insights from Lab-Grown Retinas
In a groundbreaking study, scientists at Johns Hopkins University have made significant strides in our understanding of retinal development and…
Posted inBiotechnology
February 13, 2026: Must-Read Ahead-of-Print Insights from The Journal of Nuclear Medicine
Reston, VA (February 13, 2026) — A wave of pioneering research in nuclear medicine and molecular imaging has just been…
Posted inBiotechnology
Boosting Relationship Confidence Enhances Individual Well-Being, Study Finds
URBANA, Ill. – Recent research from the University of Illinois Urbana-Champaign has unveiled new insights into the profound impacts that…
Posted inBiotechnology
Tracking Individuals Affected by Natural Disasters
A groundbreaking study led by researcher Francisco Vallés Morán from the Institute of Water and Environmental Engineering (IIAMA) at the…
Posted inBiotechnology
Engineered Exosome Nanovesicles Deliver Antibodies for IBD
In a groundbreaking advancement that holds transformative potential for the treatment of chronic inflammatory diseases, scientists have engineered exosome nanovesicles…
Posted inGenetics
Pod-Based, On-Demand Media and Buffer Manufacturing System
Credit: Extreme Media/Getty Images Nucleus Biologics launched the Krakatoa® K500, which the company says is the first bioreactor-scale, pod-based media…
Posted inBiotechnology
FDA rejects Disc’s rare disease drug despite commissioner’s voucher
The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that had been granted expedited review…
Posted inBiotechnology
Biopharma funding to experience ‘continued, albeit disciplined’ recovery in 2026: PitchBook
Just as a disciplined a soccer player might pass on a hopeful shot in favor of a better chance later…